Chen Stephen L, Morgan Timothy R
Gastroenterology Section, VA Medical Center, Long Beach, California, USA.
Int J Med Sci. 2006;3(2):47-52. doi: 10.7150/ijms.3.47. Epub 2006 Apr 1.
Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma, as well as the most common indication for liver transplantation in many countries. Although the incidence of hepatitis C infection has dramatically decreased during the past decade, the worldwide reservoir of chronically infected persons is estimated at 170 million, or 3% of the global population. There is much controversy surrounding the natural history of hepatitis C infection. The rate of chronic HCV infection is affected by a person's age, gender, race, and viral immune response. Approximately 75%-85% of HCV-infected persons will progress to chronic HCV infection, and are at risk for the development of extrahepatic manifestations, compensated and decompensated cirrhosis, and hepatocellular carcinoma (HCC). The rate of progression to cirrhosis is highly variable, and is influenced by several factors, including the amount of alcohol consumption, age of initial HCV infection, degree of inflammation and fibrosis on liver biopsy, HIV and HBV coinfection, and comordid conditions. An estimated 10%-15% of HCV-infected persons will advance to cirrhosis within the first 20 years. Persons with cirrhosis are at increased risk of developing HCC. An understanding of the natural history of hepatitis C is essential to effectively manage, treat, and counsel individuals with HCV infection.
丙型肝炎病毒(HCV)是导致慢性肝病、肝硬化和肝细胞癌的主要原因,也是许多国家肝移植最常见的适应证。尽管在过去十年中丙型肝炎感染的发病率已大幅下降,但据估计,全球慢性感染者的数量仍达1.7亿,占全球人口的3%。围绕丙型肝炎感染的自然史存在诸多争议。慢性HCV感染的发生率受一个人的年龄、性别、种族和病毒免疫反应影响。大约75%-85%的HCV感染者会进展为慢性HCV感染,并有发生肝外表现、代偿期和失代偿期肝硬化以及肝细胞癌(HCC)的风险。进展为肝硬化的速率差异很大,并受多种因素影响,包括饮酒量、初次感染HCV的年龄、肝活检时的炎症和纤维化程度、HIV和HBV合并感染以及合并症。估计10%-15%的HCV感染者会在最初20年内发展为肝硬化。肝硬化患者发生HCC的风险增加。了解丙型肝炎的自然史对于有效管理、治疗和咨询HCV感染者至关重要。